To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Nature Medicine, ISSN 1078-8956, E-ISSN 1546-170X, Vol. 25, nr 12, s. 1894-1904Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F0) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F1-F3 offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F1-F3 offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.

sted, utgiver, år, opplag, sider
Nature Publishing Group, 2019. Vol. 25, nr 12, s. 1894-1904
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-78552DOI: 10.1038/s41591-019-0666-1ISI: 000500824900033PubMedID: 31792459Scopus ID: 2-s2.0-85075981179OAI: oai:DiVA.org:oru-78552DiVA, id: diva2:1378693
Forskningsfinansiär
Novo Nordisk, NNF17OC0026724 NNF18OC0033992 NNF19OC0056647The Karolinska Institutet's Research FoundationSwedish Society for Medical Research (SSMF)Åke Wiberg FoundationStockholm County CouncilThe Royal Swedish Academy of Sciences, BS2015-0012
Merknad

Funding Agencies:

Swedish Medical Research Council (SMRC) 2014-2775 2018-02435 2014-2870 2018-02119

Strategic Research Program in Diabetes at the Karolinska Institutet  

Adlerbertska Research Foundation 

Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDECYT 1071007 1151531 1181798

Tilgjengelig fra: 2019-12-13 Laget: 2019-12-13 Sist oppdatert: 2025-02-10bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Larsson, Henrik

Søk i DiVA

Av forfatter/redaktør
Larsson, Henrik
Av organisasjonen
I samme tidsskrift
Nature Medicine

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 443 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf